NEW YORK, Jan. 13, 2017 -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Fenix Parts, Inc. (“Fenix” or the “Company”) (NASDAQ:FENX) of the March 13, 2017 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against the Company and certain officers.
The lawsuit has been filed in the U.S. District Court for the District of New Jersey on behalf of all those who purchased Fenix stock or options between May 14, 2015 and October 12, 2016 (the “Class Period”). The case, BEEZLEY v. FENIX PARTS, INC. et al, No. 17-cv-00233 was filed on January 12, 2017.
The lawsuit focuses on whether the Company and its executives violated federal securities laws by failing to maintain proper accounting which resulted in misguiding financial statements.
First, on September 10, 2015, Street Sweeper published the article, “Fenix Parts: This Automobile Parts Seller Could Be Headed To The Junkyard” revealing the Company’s lack of adequate inventory valuation methodologies. After the announcement, Fenix’s share price fell from $9.59 per share on September 9, 2015 to a closing price of $8.47 on September 10, 2015—a $1.12 or a 11.7% drop.
Then, on October 13, 2016, the Company issued a press release announcing that it would be unable to file its quarterly report for the second quarter of 2016 and that it had received a subpoena from the Securities and Exchange Commission. The subpoena is focused on the Company’s recent change in its independent registered public accounting firm, its previously announced business combinations and related goodwill impairment charge, the effectiveness of its internal control over financial reporting and its inventory valuation methodology. After the announcement, Fenix’s share price fell from $3.87 per share on October 12, 2016 to a closing price of $3.42 on October 13, 2016 — a $0.45 or a 11.63% drop.
Request more information now by clicking here: www.faruqilaw.com/FENX. There is no cost or obligation to you.
Take Action
If you invested in Fenix stock or options between May 14, 2015 and October 12, 2016 and would like to discuss your legal rights, visit www.faruqilaw.com/FENX. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to [email protected]. Faruqi & Faruqi, LLP also encourages anyone with information regarding Fenix’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class that is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
FARUQI & FARUQI, LLP 685 Third Avenue, 26th Floor New York, NY 10017 Attn: Richard Gonnello, Esq. [email protected] Telephone: (877) 247-4292 or (212) 983-9330


SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances 



